Researchers identify a crucial protein that commands a key communications hub determining cell growth

January 3, 2018, National University of Singapore
Researchers identify a crucial protein that commands a key communications hub determining cell growth
A cell image showing the precise compartment called endosome (some are shown in arrows) where BPGAP1 interacts with its partner proteins to execute growth signaling. Credit: National University of Singapore

National University of Singapore biologists have identified a crucial protein that commands a key communications hub which determines cell growth.

Various proteins control key physiological functions when their activities are properly regulated. However, the same set of proteins could lead to undesirable outcomes if their amounts are at abnormal levels or their cell-to-cell communications are short-circuited. Two cell signalling pathways, the RAS/MEK and JNK pathways (named after distinct proteins that play crucial roles in controlling cell growth and cell death, respectively) are well-known to influence the way grow, divide or even commit suicide. Although various studies have shown that these two pathways can work in parallel or together to control cell fates, it is not clear how they influence or work with each other to promote cell proliferation, which can sometimes prime cells towards uncontrolled growth in cancers.

A team of researchers led by Prof Boon Chuan LOW from the Department of Biological Sciences, NUS has identified BPGAP1 as the key scaffold protein that is responsible for linking these two major signalling pathways together. This protein acts like a switch controlling the genetic programming for . When this is functioning properly, the two pathways can communicate with each other to maintain a balance in cell numbers. If it malfunctions, it could lead to uncontrolled growth of cells, causing cancer development. The team has also established the crucial steps involved in this precise activation mechanism at the cellular and molecular levels.

"The abnormal activation of certain proteins (epidermal growth factor receptor, RAS, MEK and JNK) are known to be associated with different ways of causing cancers. The identification of BPGAP1 represents a new one-stop hub that controls these activities. This opens the way for developing potential new therapeutics that could prevent tumour ," said Prof Low, who is also a Senior Principal Investigator at the Mechanobiology Institute, NUS.

The group plans to further delineate the precise sites and structure of the interaction between BPGAP1 and the JNK and MEK proteins, so as to pinpoint the most desirable sites on the molecule for the development of anti-cancer therapeutics.

Explore further: Cancer-causing virus mimics host signal to drive cell growth, protein production

More information: T Jiang et al. BPGAP1 spatially integrates JNK/ERK signaling crosstalk in oncogenesis, Oncogene (2017). DOI: 10.1038/onc.2016.466

Related Stories

Cancer-causing virus mimics host signal to drive cell growth, protein production

June 27, 2016
As scientists identify ways that viruses exploit their host cells to make more copies of themselves, they are also uncovering clues to how these viral invaders can trigger cancerous cell growth.

Disrupting cell signals may lead to new cancer treatments

April 29, 2013
(Medical Xpress)—Scientists have taken a major step towards developing new treatments for certain cancers by disrupting the internal cellular signals that lead to the uncontrolled growth of cancerous cells.

Mechanobiology provides insight into disease and healing processes

March 19, 2015
Researchers in Singapore are gaining further insight into how the mechanical environment of cells drives fundamental cellular processes such as motility, growth and survival. These processes are integral to many clinical ...

New approaches to cell study contributes to cancer research

September 12, 2014
At Ryerson, some of our top researchers are committed to finding out how cells function, and to building our knowledge of the basic science of cellular function while investigating diseases and the potential for new therapies ...

Plant flavonoid luteolin blocks cell signaling pathways in colon cancer cells

January 23, 2012
Plant flavonoid luteolin blocks cell signaling pathways in colon cancer cells

Finding new cancer drugs in the neighborhood

January 24, 2017
Cancer is caused by an accumulation of genetic changes in a cell, that overcome the normal checks and balances leading to uncontrolled growth. A complex, interacting network of proteins controls all of a cell's processes, ...

Recommended for you

Two ways cancer resists treatment are actually connected, with one activating the other

December 18, 2018
Drugs that target BRAF and MEK in cancer have shown promise in treating a subset of melanoma that carries a mutation in the BRAF gene, but drug resistance usually emerges, reversing the benefit of these drugs and limiting ...

HPV discovery raises hope for new cervical cancer treatments

December 18, 2018
Researchers at the University of Virginia School of Medicine have made a discovery about human papillomavirus (HPV) that could lead to new treatments for cervical cancer and other cancers caused by the virus.

Vaccine, checkpoint drugs combination shows promise for pancreatic cancers

December 18, 2018
Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, demonstrating a possible pathway for treatment of people ...

Researchers identify ways breast cancer avoids immune system detection

December 18, 2018
Recent breakthroughs in immunotherapy are making a huge difference in treating some forms of cancer, especially metastatic cancer. But breast cancer has proven a tricky foe for this new therapy, and an interdisciplinary team ...

Metal chemotherapy drugs boost the impact of immunotherapy in cancer

December 18, 2018
Due to their powerful tumour-killing effect, metal-based chemotherapies are frequently used in cancer treatment. However, it was hitherto assumed that they damaged the immune system, because of their cytotoxic (cell-damaging) ...

10-year follow-up after negative colonoscopies linked to lower colorectal cancer risk

December 17, 2018
Ten years after a negative colonoscopy, Kaiser Permanente members had 46 percent lower risk of being diagnosed with and were 88 percent less likely to die from colorectal cancer compared with those who did not undergo colorectal ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.